Get started

BioXcel Therapeutics, Inc. (United States)

Alternate names: BioXcel Therapeutics, BioXcel Therapeutics, Inc.
ROR: 036jes192
OpenAlex ID: I4405267542
Green process chemistry in the pharmaceutical industry
2009 · Berkeley W. Cue, Ji Zhang · Green Chemistry Letters and Reviews · 221
PDF
Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets
2021 · Estibaliz Gómez-de-Mariscal, Vanesa Guerrero, et al. · Scientific Reports · 120
PDF
Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia
2018 · Florence F. Wagner, Lina Benajiba, et al. · Science Translational Medicine · 103
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder
2022 · Sheldon H. Preskorn, Scott Zeller, et al. · JAMA · 94
Use of Anti-CD3 × Anti-HER2/neu Bispecific Antibody for Redirecting Cytotoxicity of Activated T Cells Toward HER2/neu + Tumors
2001 · Manjula Sen, Dawn M. Wankowski, et al. · Stem Cells and Development · 92
Phytic Acid as a Potential Treatment for Alzheimer's Pathology: Evidence from Animal and in vitro Models
2011 · Thimmappa S. Anekonda, Teri L. Wadsworth, et al. · Journal of Alzheimer s Disease · 86
New technologies for making vaccines
1999 · Ronald W Ellis · Vaccine · 85
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
2021 · Allison A Fitzgerald, Shangzi Wang, et al. · Journal for ImmunoTherapy of Cancer · 84
PDF
The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues
2017 · Ashley M. Smith, Katie K. Maguire-Nguyen, et al. · npj Regenerative Medicine · 70
PDF
Development of Isothermal TaqMan Assays for Detection of Biothreat Organisms
2008 · Yanhong Tong, Wen Tang, et al. · BioTechniques · 49
Primase-based whole genome amplification
2008 · Ying Li, Hyun-Jin Kim, et al. · Nucleic Acids Research · 48
PDF
Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics
2018 · Samuel Kogan, Darren R. Carpizo · Cancers · 46
PDF
Co-option of neurotransmitter signaling for inter-organismal communication in C. elegans
2019 · Christopher D. Chute, Elizabeth M. DiLoreto, et al. · Nature Communications · 36
PDF
Candidate Neisseria meningitidis NspA vaccine
2000 · Denis Martin, Bernard R Brodeur, et al. · Journal of Biotechnology · 36
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder
2022 · Leslie Citrome, Sheldon H. Preskorn, et al. · The Journal of Clinical Psychiatry · 34
PDF
Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3
2022 · Xiuli Zhao, Annika B. Ozols, et al. · Molecular Psychiatry · 26
Improving isothermal DNA amplification speed for the rapid detection of Mycobacterium tuberculosis
2010 · Aurélie Motré, Richard Kong, et al. · Journal of Microbiological Methods · 26
Fractional re-distribution among cell motility states during ageing
2021 · Jude M. Phillip, Nahuel Zamponi, et al. · Communications Biology · 24
PDF
The importance and future of biochemical engineering
2020 · Timothy A. Whitehead, Scott Banta, et al. · Biotechnology and Bioengineering · 17
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial
2023 · Jermaine D. Jones, Lavanya Rajachandran, et al. · The American Journal of Drug and Alcohol Abuse · 15
PDF
Immune Regulation and Oxidative Stress Reduction by Preimplantation Factor following Syngeneic or Allogeneic Bone Marrow Transplantation
2013 · Reut Shainer, Yehudith Azar, et al. · Conference Papers in Medicine · 15
PDF
First-in-class oral innate immune activator BXCL701 combined with pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC) of small cell neuroendocrine (SCNC) phenotype: Phase 2a final results.
2023 · Rahul Raj Aggarwal, Jingsong Zhang, et al. · Journal of Clinical Oncology · 14
PDF
Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy
2024 · Jing‐Hong Ma, Chong Dong, et al. · Movement Disorders · 10
PDF
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
2022 · Leslie Citrome, Robert Risinger, et al. · Advances in Therapy · 9
PDF
Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment
2024 · Arianna Bassan, Ronald Steigerwalt, et al. · Frontiers in Toxicology · 8
PDF
Works count: 78
Citation count: 2,981
Year
Topic
Type